Harnessing the power of biochemistry and technology to detect early signs of emotional distress.
Our early detection tools are designed to help healthcare professionals identify biological indicators of emotional distressbefore symptoms escalate.
By integrating biochemical data with digital assessment, NeuroPath enables proactive, personalized care — long before self-harming or depressive behaviours emerge.
We combine cutting-edge metabolomics with psychometric insight to build a new generation of objective, evidence-based diagnostics for mental health.
Therapeutics Development
Therapeutics Development: At NeuroPath Biosciences, we are working on developing cutting-edge therapeutics to treat NSSI and related mental health conditions. Through rigorous research and testing, we aim to create effective, evidence-based treatments that improve the quality of life for those affected by NSSI.
Our ongoing research focuses on uncovering the underlying causes and drivers of NSSI. We collaborate with leading experts to generate new insights that shape our development of tools and therapies.